YD Bio Limited Ordinary Shares (YDES) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

YD Bio Limited Ordinary Shares (YDES) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $450.5M, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.12 to the broader market. YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. Led by Ethan Shen, public since 2025-08-29.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for YDES as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →